In a hemodynamically stable 30-year-old woman with narrow‑complex supraventricular tachycardia, dizziness, shortness of breath after alcohol ingestion and no evidence of aberrant conduction, what is the most appropriate management?

Management of Narrow QRS Complex Tachycardia in a Hemodynamically Stable Young Woman

Begin with vagal maneuvers immediately, followed by intravenous adenosine if vagal maneuvers fail—this is the definitive first-line management for this hemodynamically stable patient with narrow-complex supraventricular tachycardia.

Algorithmic Approach to Acute Management

Step 1: Confirm Hemodynamic Stability

This 30-year-old woman has dizziness and shortness of breath but appears hemodynamically stable (no hypotension, altered mental status, signs of shock, or acute heart failure). Hemodynamic stability determines the entire treatment pathway 1.

Step 2: First-Line Therapy - Vagal Maneuvers

• Perform vagal maneuvers first with the patient in the supine position 1
• Modified Valsalva maneuver: Have patient bear down against a closed glottis for 10-30 seconds, generating at least 30-40 mm Hg intrathoracic pressure 1
• Alternative: Apply ice-cold wet towel to face (diving reflex) 1
• Carotid sinus massage: After confirming no bruit, apply steady pressure over right or left carotid sinus for 5-10 seconds 1
• Success rate approximately 28% when switching between techniques 1

Step 3: Second-Line Therapy - Adenosine

If vagal maneuvers fail, adenosine is the drug of choice 2, 1

• Effectiveness: 90-95% conversion rate for narrow-complex SVT 1
• Administration: Rapid IV bolus via proximal vein followed by saline flush 1
• Critical safety point: Have electrical cardioversion immediately available, as adenosine can precipitate atrial fibrillation that may conduct rapidly 1
• Side effects are minor and brief (<1 minute): chest discomfort, shortness of breath, flushing 1, 3
• Continuous ECG recording during administration helps distinguish failure to terminate versus successful termination with immediate reinitiation 1

Step 4: Alternative Pharmacologic Options (If Adenosine Fails or Contraindicated)

Intravenous calcium channel blockers or beta-blockers are reasonable alternatives 1:

• IV diltiazem or verapamil: 64-98% termination rate; slow infusion over 20 minutes reduces hypotension risk 1
• IV beta-blockers: Excellent safety profile though slightly less effective than calcium channel blockers 1

Critical caveat: The 2019 ESC guidelines downgraded verapamil and diltiazem from their previous recommendations, while adenosine remains the clear first choice 2. However, these agents remain reasonable second-line options per ACC/AHA guidelines 1.

Step 5: Electrical Cardioversion (If Pharmacotherapy Fails)

Synchronized cardioversion is recommended when all pharmacologic therapy fails or is contraindicated 1

• Highly effective for terminating SVT 1
• Performed after adequate sedation/anesthesia in stable patients 1
• Success rates for pharmacotherapy are 80-98%, so cardioversion is rarely needed in stable patients 1

Important Clinical Considerations

No Evidence of Aberrant Conduction

The absence of aberrant conduction (no pre-excitation/delta waves) is crucial because:

• AV nodal blocking agents are safe in this patient 1
• If pre-excitation were present, calcium channel blockers and beta-blockers could be dangerous in atrial fibrillation by enhancing accessory pathway conduction 1

Alcohol as Trigger

Alcohol is a recognized precipitant of SVT 1. This context supports the diagnosis but doesn't change acute management.

Age and Gender Context

• SVT risk is twice as high in women 2
• This demographic commonly presents with palpitations (86%), chest discomfort (47%), and dyspnea (38%) 3
• Tachycardia-mediated cardiomyopathy is rare (1%) but a consideration if episodes are frequent or prolonged 2, 3

Common Pitfalls to Avoid

1. Do not use amiodarone or digoxin for acute narrow-complex SVT—these are no longer recommended 2
2. Ensure cardioversion equipment is available before giving adenosine 1
3. Avoid calcium channel blockers if systolic heart failure is suspected 1
4. Do not give AV nodal blockers if pre-excited atrial fibrillation is possible (though not applicable here given no aberrant conduction) 1

Post-Conversion Management

After successful conversion, consider:

• Catheter ablation as first-line definitive therapy: 94.3-98.5% single-procedure success rate 3
• Long-term pharmacologic prophylaxis with oral beta-blockers, diltiazem, or verapamil if ablation declined 1
• The 2019 ESC guidelines significantly upgraded catheter ablation to preferential status for symptomatic recurrent SVT 2, 4